We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Focused Ultrasound May Benefit Patients with Epilepsy

By HospiMedica International staff writers
Posted on 17 Nov 2021
Image: Focused ultrasound being delivered using neuronavigation and EEG monitoring (Photo courtesy of Hsiang-Yu Yu/ VGHTPE)
Image: Focused ultrasound being delivered using neuronavigation and EEG monitoring (Photo courtesy of Hsiang-Yu Yu/ VGHTPE)
A new study suggests that focused ultrasound (FUS) of the brain may benefit patients with drug-resistant epilepsy (DRE).

Researchers at National Yang Ming Chiao Tung University (NYCU; Taipei, Taiwan), Taipei Veterans General Hospital (Taiwan), and other institutions conducted a study in six DRE patients who were scheduled to undergo stereo-electroencephalography (SEEG) for localization of the seizure onset zone (SOZ), providing a window of opportunity to investigate the neuromodulatory effects of FUS. Simultaneous SEEG recordings were obtained during sonication and for three days after treatment to monitor seizures, interictal epileptiform discharges, and adverse events.

The results revealed a decrease in seizure frequency in two patients within the three-day follow-up, with significant changes in spectral power of SEEG noted at the targeted electrodes during FUS; one patient showed an increase in the frequency of subclinical seizures. Magnetic resonance imaging (MRI) revealed neither lesion nor brain edema. One patient reported subjective scalp heating during FUS, and one patient developed transient naming and memory impairment that resolved within three weeks. The study was published on November 2, 2021, in Epilepsia.

“Neuromodulation is an alternative treatment for drug-resistant epilepsy. Compared with the present modalities used in neuromodulation for epilepsy, focused ultrasound can access deeper brain regions and focus on the main target of the epileptic network in a relatively less invasive approach,” said senior author Hsiang-Yu Yu, PhD, of VGHTPE and the NYCU Brain Research Center. “It gives new hope and sheds new light for patients with drug-resistant epilepsy.”

Focused ultrasound is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be treated, while the surrounding tissue retains as little damage as possible.

Related Links:
National Yang Ming Chiao Tung University
Taipei Veterans General Hospital


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Patient Preoperative Skin Preparation
BD ChloraPrep

Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more